The aim of this study was to determine if increased expression of heme oxygenase (HO) contributes to impairment of aortic contractile responses after hypoxia through effects on reactivity to endothelin-1 (ET-1). Thoracic aortas from normoxic rats and from rats exposed to hypoxia (10% O 2 ) for 16 or 48 hours were mounted in organ bath myographs for contractile studies, fixed in paraformaldeyde or frozen in liquid nitrogen for later protein extraction. In rings from normoxic rats, the HO inhibitor tin protoporphyrin IX (SnPP IX, 10 µmol/L) did not alter the response to phenylephrine or ET-1. In rings from rats exposed to hypoxia for 16 hours, maximum tension generated in response to these agonists was higher in endothelium-intact but not -denuded rings in the presence of SnPP IX. In rings from rats exposed to hypoxia for 48 hours SnPP IX increased contraction in endothelium-intact but not -denuded rings. In endothelium-intact aortic rings from rats exposed to hypoxia for 16 hours incubated with the endothelin A receptor-specific antagonist BQ123 (10 -7 M) , SnPP IX did not alter phenylephrineinduced contraction. Aortic endothelin-1 protein levels, measured by radioimmunoassay, were increased in rats exposed to hypoxia for 16 and 48 hours. Western blotting showed that HO-1 and HO-2 protein were increased after 16hrs of hypoxia and had returned to near control levels after 48 hours. The increase in HO-1 protein was detected in both endothelium-intact and denuded rings. Removal of the endothelium abolished the increase in HO-2 immunoreactivity.
INTRODUCTION
The endothelins are potent vasoconstrictor peptides released by endothelial cells in response to a variety of stimuli. Hypoxia is a particularly potent activator of endothelin-1 (ET-1) production (19, 47) and recent studies indicate that ET-1 plays a central role in the adaptation to hypoxia, regulating peripheral chemoreceptor sensitivity (36) , and potentiating the vascular responses that enhance pulmonary gas exchange and tissue oxygen extraction (5, 34, 48, 52) .
Given the need to balance these important functions with the potential for exacerbation of ischemic injury through excessive vasoconstriction (6) , it is not surprising that mechanisms have evolved to modulate the local bioavailability and potency of ET-1 in order to preserve the relationship between regional oxygen delivery and metabolic demand (20, 46) .
Heme oxygenase (HO), the rate limiting enzyme in the heme catabolic pathway that yields bilirubin as the final product, catalyses the formation of biliverdin through the elimination of the α-methene carbon bridge of the porphyrin ring as carbon monoxide (CO) (24). Both biliverdin and bilirubin possess antioxidant properties and, therefore, the capacity to suppress intracellular concentrations of the reactive oxygen species which regulate ET-1 precursor mRNA expression (18, 37) and which serve as second messengers in ET-1 signaling (22) . Carbon monoxide mimics many nitric oxide (NO) functions including cyclic GMP-dependent andindependent inhibition of agonist induced vascular smooth muscle contraction (29, 44, 45) . The products of the reaction catalysed by HO, therefore, have the capacity to attenuate ET-1 mediated effects at multiple levels. HO expression is hypoxia inducible in vascular cells (30) and modulates arterial reactivity in some vascular beds. Accordingly, the current study was carried out to determine if HO contributes to the change in aortic contractile responses after H-01218-2003.R1 exposure to hypoxia (2) and the extent to which this is due to modulation of the effect of locally produced ET-1.
MATERIALS AND METHODS
Studies were carried out in male Sprague-Dawley rats (200-250 g). All protocols were in accordance with standards set by the Canadian Council on Animal Care and were approved by the institutional animal care committee. As described previously (2) , rats were placed in a Plexiglas chamber (30 cm × 18 cm × 15 cm) into which the flow of air and nitrogen were controlled independently. Oxygen concentration in the chamber was monitored continuously using an oxymeter (Engineered Systems Design, Oxan 1501, Wilmington, Delaware) and air and nitrogen flow were adjusted such that animals exposed to hypoxia breathed a mixture containing 10% O 2 throughout the hypoxia exposure period, whereas, control animals breathed air only under otherwise identical conditions. Thoracic aortas were excised immediately after decapitation and either mounted in organ bath myographs, frozen in liquid nitrogen for later protein extraction or fixed for immunohistochemical studies.
Tin protoporphyrin IX (SnPP IX) and copper protoporphyrin IX (CuPP IX) were purchased from Porphyrin Products (Logan, UT). BQ123 was from the American Peptide Company (Sunnyvale, CA). All other chemicals were purchased from Sigma Chemical (St.
Louis, MO). Monoclonal HO-1 and polyclonal HO-2 antibodies were obtained from StressGen (Victoria, British Columbia). Rabbit anti-ET-1 antiserum was from Peninsula Laboratories (Belmont, CA). Immunohistochemical reagents were bought from the DAKO Corporation (Carpinteria, CA). Electrophoresis reagents were from BioRad (Mississauga, Ontario Cumulative concentration-response relationships for phenylephrine (10 -9 to 10 -5 M) were generated in endothelium-intact and -denuded aortic rings from normoxic rats and from rats exposed to hypoxia for 16 and 48 hours after 30 minutes incubation with, and in the continuous presence of 0.1% DMSO (vehicle) or the HO inhibitor SnPP IX (10 µmol/L). Phenylephrine concentration-response relationships were also generated in the presence of the inactive protoporphyrin cogener CuPPIX (30 µmol/L) in endothelium-intact and -denuded rings from rats exposed to hypoxia for 16 hours, the time point at which the SnPP IX effect was found to be maximal, to test for non-specific effects.
To establish the relative importance of HO and NO pathways in inhibition of aortic reactivity after hypoxia and to ensure that effects of SnPP IX are not due to non-specific inhibition of NO synthesis (1). Concentration-response relationships for phenylephrine were generated in the presence of vehicle (DMSO), the nitric oxide synthase (
nitro-L-arginine methyl ester (L-NAME, 10 µmol/L), SnPP IX (10 µmol/L) or both L-NAME and SnPP IX in endothelium-intact aortic rings from rats exposed to hypoxia for 16 hours, the time point at which maximum HO-2 expression was noted (see below),
In order to evaluate the role of effects on endothelin A receptor (ET A R) activation and/or signaling in the enhancement of aortic contraction by HO inhibition observed in hypoxiaexposed rats, concentration-response relationships for phenylephrine were generated in a separate group of endothelium-intact aortic rings from rats exposed to normoxia or hypoxia for 16 hours and 48 hours in the presence of vehicle (DMSO), the ET A R-specific antagonist BQ123
(1 µmol/L), SnPP IX (10 µmol/L) or both BQ123 and SnPP IX. As reported in a previous study (52) this concentration of BQ123 completely inhibited the response to ET-1 in rat aorta with no effect on phenylephrine-induced contraction in endothelium-intact or -denuded aortic rings from normoxic rats or in endothelium-denuded aortic rings from rats exposed to hypoxia.
To confirm that the failure to detect an effect of SnPP IX on phenylephrine induced contraction in endothelium-denuded rings is due to the dependence of this effect on the presence of endothelial HO rather than to removal of the source of endogenous ET-1 production, concentration-response relationships for ET-1 (10 -11 to 10 -7 M) were generated in endotheliumintact and -denuded aortic rings from rats exposed to normoxia and hypoxia for 16 hours in the presence of DMSO, SnPP IX (10 µmol/L) and CuPP IX (30 µmol/L). The 16 hour time point was chosen for these studies because this is the duration of hypoxic exposure at which HO protein levels reached their maximum (see below) and the effect of SnPP IX on phenylephrine responses in endothelium-intact aortic rings was most apparent.
ET-1 Radioimmunoassay:
Rat aortic ET-1 content was determined as previously described (38). Briefly, ET-1 was extracted from the supernatant of rat aortic homogenates using SepPak- 
RESULTS

Functional Studies:
The effects of SnPP IX on the concentration-response relationship for phenylephrine in endothelium-intact and -denuded aortic rings from normoxic rats and rats exposed to hypoxia are illustrated in figure 1 . Maximum tensions generated and the
concentrations of phenylephrine that elicit a 50% maximal response (EC 50 ) are presented in table   1 . SnPP IX did not alter phenylephrine-evoked responses in rings from normoxic rats or in rings from hypoxia-exposed rats that had been denuded of endothelium. In contrast, endotheliumintact rings from rats exposed to hypoxia for 16 hours and 48 hours produced greater tension and demonstrated greater sensitivity (decreased EC 50 ) to phenylephrine in the presence of SnPP IX than in the in the presence of vehicle only (Table 1) . CuPP IX, the inactive cogener, had no effect on the response to phenylephrine (data not shown).
The effects of treatment with SnPP IX, L-NAME, and both, on phenylephrine-induced contraction in endothelium-intact aortic rings from rats exposed to hypoxia for 16 hours are illustrated in figure 2 . The maximum tension generated during phenylephrine-induced contraction in the presence of SnPP IX (1.426 ± 0.055 g/mg dry weight) and L-NAME (1.491 ± 0.031 g/mg dry weight) did not differ. The maximum tension generated in rings treated with both SnPP IX and L-NAME (1.93 ± 0.045 g/mg dry weight) was greater than that recorded in the presence of either agent alone and the increase in tension in rings treated with both agents over that recorded in rings exposed to vehicle alone (1.036 ± 0.071 g/mg dry weight) did not differ from the sum of the corresponding increases resulting from treatment with the individual antagonists.
Concentration response relationships for phenylephrine obtained in endothelium-intact aortic rings from rats exposed to hypoxia for 16 and 48 hours in the presence of vehicle alone (DMSO), SnPP IX, BQ123 (1 µmol/L) and both SnPP IX and BQ123 are presented in Figure 3 .
In endothelium-intact rings from these groups the phenylephrine concentration response relationship recorded in the presence of both SnPP IX and BQ123 did not differ from that obtained in the presence of BQ123 alone. As expected, given that neither SnPP IX nor BQ123
H-01218-2003.R1
had any effect on phenylephrine-induced contraction in aortic rings from normoxic animals, the combination of these two antagonists also did not alter the phenylephrine response in rings from normoxic rats (data not shown).
The effect of SnPP IX (10 µM) on ET-1 induced contraction is illustrated in figure 4 . In endothelium-intact but not -denuded aortic rings from rats exposed to hypoxia for 16 hours SnPP IX, enhanced the contractile response. The inactive cogener, CuPP IX (30 µM) had no effect.
SnPP IX had no effect on ET-1-induced contraction in either endothelium-intact or -denuded aortic rings from normoxic animals (data not shown).
Aortic ET-1 Levels:
The results of the ET-1 radioimmunoassay in endothelium-intact and endothelium-denuded aortic segments from rats exposed to normoxia and to hypoxia for 16 and 48 hours are presented in figure 5 . Hypoxia increased ET-1 levels in intact rat aortic segments (P<0.01, 16 and 48 hours hypoxic vs. normoxic control group). In endothelium-denuded aortic segments ET-1 levels did not differ between hypoxia-exposed and normoxic animals, localizing the increase in ET-1 production to the endothelium.
Western Blots:
Levels of both HO isoforms were increased in aortic homogenates after 16 hours of hypoxia and had returned to near control levels after 48 hours of hypoxic exposure ( Figure 6 ). Removal of the endothelium had no effect on the increase in HO-1 protein level recorded after 16 hours of hypoxia indicating that the majority of this increase occurred within the aortic media. In contrast no increase in aortic HO-2 protein was detected in endotheliumdenuded segments from hypoxia-exposed compared to normoxic rats localizing the increase in this isoform to the endothelial cell layer.
Immunohistochemistry:
Immunohistochemical staining using HO-1 and -2 specific antisera failed to detect either isoform in aortic sections from normoxic animals. In aortas from rats H-01218-2003.R1
exposed to hypoxia HO-1 immunoreactivity was observed in both endothelium and smooth muscle. HO-2 was detected only in the endothelium in aortas from hypoxia exposed animals ( Figure 7 ).
DISCUSSION
We found that: 1) HO inhibition with SnPP IX increases the contractile responses to phenylephrine and ET-1 in endothelium-intact but not -denuded aortic rings from hypoxiaexposed rats; 2) SnPP IX enhancement of phenylephrine contraction in aortic rings from rats exposed to hypoxia is completely inhibited by the ET A receptor-specific antagonist BQ123; 3) in endothelium intact aortic rings from rats exposed to hypoxia for 16 hours, the increase in tension after treatment with SnPP IX is comparable in magnitude and additive to the effect of NOS inhibition with L-NAME; 4) in contrast to aortic ET-1 levels which increase with the duration of hypoxic exposure, HO-1 and HO-2 protein levels are increased after 16 hours of hypoxia and return to near control levels after 48 hours; and 5) HO-1 is increased in the smooth muscle of aortas from rats exposed to hypoxia whereas increases in ET-1 and HO-2 immunoreactivity are localized to the endothelium.
The contributions of smooth muscle-and endothelium-dependent mechanisms in the alteration in systemic vasoreactivity after hypoxia have varied among vessels from different anatomical sites, in different species and with the duration of the hypoxic epoch. In rat aorta (2, 51) and diaphragmatic arterioles (41) after 16 to 48 hours of hypoxia, and in rat iliac artery (3, 4) and ovine uterine artery (16) after 4 to 6 weeks of hypoxia, the primary locus of contractile impairment is the vascular smooth muscle. In keeping with our current findings, a potentially compensatory alteration in the function of the endothelium, in that it becomes an agency of vasoconstriction as opposed to its normal role as a source of vasorelaxing factors, was also noted
in these preparations (2-4, 41, 52). In rat mesenteric artery strips, in contrast, 48 hours of hypoxia results in endothelium-dependent hyperpolarization of the smooth muscle which contributes to impaired pressure and phenylephrine induced contraction (11) .
A large body of evidence now supports a role for HO-derived CO in the alterations in pulmonary (31) (8) (43). (50) and systemic (7) vascular reactivity that develop during hypoxia.
Heme oxygenases-1 and -2 have been detected in both systemic vascular endothelial and smooth muscle cells (9, 29, 30, 32, 53) . However, since HO inhibition had no effect on contractile responses in endothelium-denuded aortic segments in the current study ( figure 1D and 1F, table 1), our results suggest that physiologically relevant CO production after exposure to hypoxia is primarily localized to the endothelium. Consistent with this conclusion, prior studies have demonstrated that the effect of HO inhibition on contraction and membrane depolarization in mesenteric arteries and on contraction in aortic segments from chronically hypoxic rats is eliminated by endothelial ablation (7, 11, 32) . Since vascular cell expression of HO-1 has been shown to be hypoxia inducible (29, 30) , whereas that of HO-2 has not, these previous findings were attributed, by inference, to upregulation of HO-1 (7). In the present study, however, we found that the increase in HO-2 rather than HO-1, immunoreactivity was eliminated by endothelial ablation and conclude that it is the HO-2 isoform that primarily accounts for the increase in sensitivity of contractile responses to HO inhibition seen in endothelium-intact aortic segments after hypoxia.
The biochemical mechanisms that mediate arterial smooth muscle dysfunction after hypoxia are not completely understood, however, studies in rat aorta indicate that enhanced (17) a role for this isoform in the loss of smooth muscle reactivity after hypoxia has also been proposed. Our finding that SnPP IX has no effect on contractile responses in endothelium-denuded aortic rings from hypoxia-exposed animals ( figure 1D and 1F ) despite robust induction of aortic smooth muscle HO-1 protein expression was, therefore, unexpected.
Although the concentration of SnPP IX used in the current study is effective in inhibiting HO activity in vascular smooth muscle cells (29), we cannot rule out the possibility that a functional effect may have been seen at higher concentrations. The usefulness of such experiments, however, is limited because the specificity of metalloprotoporphyrin inhibitors is lost at higher levels (1). Moreover, the lack of an acute effect of its inhibiton on agonist-induced contraction does not exclude a vasoregulatory role for this isoform. One known function of hemeoxygenases is the degradation of heme proteins some of which, including members of the cytochrome p450
family of enzymes and the nitric oxide synthases, catalyze the basal production of potent vasoregulatory molecules. The role of HO-1 in regulating vascular tone through effects on the enzymatic capacity of these pathways, therefore, requires evaluation.
HO-1 expression is primarily regulated at the transcriptional level (29) and its 5' genomic region is enriched in known hypoxia regulatory elements (15, 21, 49) . In contrast, analysis of the region 5' to the rat HO-2 open reading frame reveals a glucocorticoid regulatory element but no sites corresponding to the transcription factors known to participate in the hypoxic or other cellular stress responses (27, 35) . Not surprisingly, therefore, hypoxic incubation has not resulted in upregulation of HO-2 transcription or mRNA levels in any of the cell culture systems
in which it has been evaluated (29, 47) . Despite the lack of evidence for transcriptional regulation, HO-2 protein expression is not entirely constitutive. Development-stage specific changes in HO-2 protein levels have been noted (12, 39) and cigarette smoke increases the number of lung cells expressing HO-2 protein (23). In the brain and testis, alternate HO-2 transcripts have been identified which differ in their 3' and 5'untranslated regions (25, 26, 39) and the dissociation between regional HO-2 protein and mRNA expression in testicular germ cells of differing stages suggests that HO-2 mRNA is sequestered from translation in these cells (12) . Thus mRNA sequestration, alternate promoter usage or post-transcriptional modification of mRNA structure may provide the key to understanding changes in HO-2 protein expression observed in the current study and in other instances in which a basis for transcriptional regulation is not apparent.
In endothelium-intact aortic rings from rats exposed to hypoxia for 16 hours, we found that SnPP IX enhanced contraction to approximately the same extent as did L-NAME and that these effects are additive. Classically, this would be taken to indicate that NOS-and HOmediated inhibition of contraction are of approximately equal importance and independent of each other. Carbon monoxide is significantly less potent than NO as an activator of soluble guanylyl cyclase (sGC) (13) , however, and may function as a partial sGC agonist (52).
Therefore, the effect of HO inhibition may be enhanced under conditions of NO deficiency and an interaction between these two pathways will be masked by this method of evaluation. These results do confirm that the SnPP IX effect is not attributable to NOS inhibition.
Hypoxia induces ET-1 precursor transcription in endothelial cells through the formation of a hypoxia-responsive complex that involves binding of adjacent HIF-1α, AP-1, GATA-2 and NF-1 sites and which is further modulated by interaction with the activator protein p300/CBP H-01218-2003.R1 (47) . This mechanism is inhibited, however, by CO and NO (20, 28) so our current finding that aortic ET-1 protein increases progressively concomitant with an increase in endothelial hemeoxygenase levels is somewhat surprising. Rat aortic endothelial expression of nitric oxide synthase is decreased during hypoxia (42), however, and since CO is less diffusible than NO (13) the increase in CO production may be insufficient to compensate for the loss of NO-mediated suppression. Increased levels of endothelin converting enzyme-1 have also been reported in aortas from rats exposed acutely to hypoxia (10) , therefore, the increase in aortic ET-1 protein noted in the present study may be the result of enhanced post-translational processing and insensitive to regulation at the transcriptional level.
In endothelium-intact aortic rings from hypoxia-exposed rats, we found that BQ123 Phenylephrine concentration-response curves of endothelium-intact and -denuded aortic rings from rats exposed to hypoxia for 16 hours in the presence of SnPP IX, L-NAME, both L-NAME and SnPP IX and vehicle (DMSO, 0.1%) alone. n = 6 per group. * P < 0.05 for difference from corresponding value in DMSO treated rings. P < 0.05 for differences between rings treated with either L-NAME or SnPP IX and those treated with both L-NAME and SnPP IX. Endothelin-1 (ET-1) levels in endothelium-intact and -denuded thoracic aortas from rats exposed to normoxia and to hypoxia for 16 hours and 48 hours. n = 10 per group; * P < 0.05 compared to corresponding value in the normoxic control group.
Figure 6.
Top Panel: Heme oxyenase-1 (HO-1) protein levels in endothelium-intact (EC intact) anddenuded (EC removed) thoracic aortas from rats exposed to normoxia or to hypoxia for 16 hours and 48 hours (n=4 per group). * P < 0.05 compared to corresponding value in the normoxic control group.
Bottom Panel:
Heme oxygenase-2 (HO-2) protein levels in endothelium-intact (EC intact) and -denuded (EC removed) thoracic aortas from rats exposed to normoxia and to hypoxia for 16 hours and 48 hours (n=5 per group). * P < 0.05 compared to corresponding value in the normoxic control group.
Figure 7.
Heme oxygenase-1 immunoreactivity (brown diaminobenzidine staining) is apparent in the aortic smooth muscle (and endothelium in some sections) in rats exposed to hypoxia for 16 hours (A).
Heme oxygenase-2 staining is seen in the endothelium but not in the smooth muscle of aortic sections from rats exposed to hypoxia for 16 hours (B). 
